Details

Autor(en) / Beteiligte

• Russo, Andrea M., MD, FACC, FHRS
• Stainback, Raymond F., MD, FACC, FASE
• Bailey, Steven R., MD, FACC, FSCAI, FAHA
• Epstein, Andrew E., MD, FACC, FAHA, FHRS
• Heidenreich, Paul A., MD, FACC
• Jessup, Mariell, MD, FACC, FAHA
• Kapa, Suraj, MD
• Kremers, Mark S., MD, FACC, FHRS
• Lindsay, Bruce D., MD, FACC, FHRS
• Stevenson, Lynne Warner, MD, FACC

Titel

ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy

Ist Teil von

• Journal of the American College of Cardiology, 2013-03, Vol.61 (12), p.1318-1368

Ort / Verlag

New York: Elsevier Inc

Erscheinungsjahr

2013

Quelle

EZB-FREE-00999 freely available EZB journals

Beschreibungen/Notizen

• A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Technical Panel Steven R. Bailey, MD, FACC, FSCAI, FAHA, Moderator Andrea M. Russo, MD, FACC, FHRS, Writing Group Liaison* Suraj Kapa, MD, Writing Group Liaison Michael B. Alexander, MD, FACC§Health Plan Representative Steven R. Bailey, MD, FACC, FSCAI, FAHA||American College of Cardiology Foundation Representative Ulrika Birgersdotter-Green, MD, FHRS|| Alan S. Brown, MD, FACC, FAHA, FNLA|| Richard A. Grimm, DO, FACC, FASE¶American Society of Echocardiography Representative Paul J. Hauptman, MD#Heart Failure Society of America Representative Sharon A. Hunt, MD, FACC# Rachel Lampert, MD, FACC, FHRS* JoAnn Lindenfeld, MD, FACC**American Heart Association Representative David J. Malenka, MD, FACC|| Kartik Mani, MD[dagger][dagger]Society for Cardiovascular Angiography and Interventions Representative Joseph E. Marine, MD, FACC, FHRS* Edward T. Martin, MD, FACC, FACP, FAHA[double dagger][double dagger]Society for Cardiovascular Magnetic Resonance Representative Richard L. Page, MD, FACC, FHRS, FAHA|| Michael W. Rich, MD, FACC§§American Geriatrics Society Representative Paul D. Varosy, MD, FACC, FHRS* Mary Norine Walsh, MD, FACC|| Appropriate Use Criteria Task Force Michael J. Wolk, MD, MACC, Chair Steven R. Bailey, MD, FACC, FSCAI, FAHA John U. Doherty, MD, FACC Pamela S. Douglas, MD, MACC, FAHA Robert C. Hendel, MD, FACC, FAHA, FASNC Christopher M. Kramer, MD, FACC James K. Min, MD, FACC Manesh R. Patel, MD, FACC Leslee Shaw, PhD, FACC, FASNC Raymond F. Stainback, MD, FACC, FASE Joseph M. Allen, MA Table of Contents Abstract... Special Conditions/Comorbidities in Patients for Primary Prevention (Meeting Indications of ICD Implant Related to HF Diagnosis With LVEF <=30% on Guideline-Directed Medical Therapy >3 Months)... .\n Groeneveld None None None None None None Stephen Hammill None None None None None None Charles A. Henrikson None None None Boston Scientific None None Michael Ho None None None None None None Mariell Jessup None None None None None None Stuart D. Katz None None None None None None Bradley P. Knight Boston Scientific Biotronik Boston Scientific Medtronic None None None None Wayne C. Levy None None None None None None Barbara Messinger-Rapport None None None None None None Gerald V. Naccarelli Medtronic None None None None None Robert M. Palmer None None None None None None Samir B. Pancholy None Medtronic None None None None Jeanne E. Poole Biotronik Boston Scientific Medtronic St. Jude Medical None None Medtronic Boston Scientific* Medtronic* St. Jude Medical* None Subha V. Raman None None None None None None Matthew R. Reynolds Medtronic None None None None None William G. Stevenson None None None None None None Cynthia M. Tracy None None None None None None Quynh A. Truong None None None St. Jude Medical* None None Paul J. Wang Boston Scientific Medtronic None None Boston Scientific* Medtronic* None None Bruce L. Wilkoff None None None None Medtronic St. Jude Medical None Appropriate Use Criteria Task Force Michael J. Wolk None None None None None None Steven R. Bailey None None None None None None John U. Doherty None None None None None None Pamela S. Douglas None None None None None None Robert C. Hendel None None None None None None Christopher M. Kramer St. Jude Medical None None None None None James K. Min None None None None None None Manesh R. Patel None None None None None None Leslee Shaw None None None None None None Raymond F. Stainback None None None None None None Joseph M. Allen None None None None None None * This table represents the relevant relationships with industry and other entities that were disclosed by participants at the time of participation. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, or ownership of $10,000 or more of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year.